Immunic (IMUX) Other Non Operating Income (2013 - 2026)

Immunic has disclosed Other Non Operating Income across 14 years of filings, most recently posting -$113000.0 for Q1 2026.

• Other Non Operating Income for Q1 2026 came in at -$113000.0, down 109.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.7 million (up 68.65% YoY), and the FY2025 annual result was $5.0 million, up 578.17% from the prior year.
• Other Non Operating Income came in at -$113000.0 for Q1 2026 at Immunic, down from $3.8 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $3.8 million in Q4 2025 to a low of -$2.1 million in Q1 2024.
• The 5-year median for Other Non Operating Income is $54000.0 (2023), against an average of $260588.2.
• Across the five-year window, Other Non Operating Income slumped 277.61% in 2024 and soared 14085.19% in 2025, its largest moves.
• Immunic's Other Non Operating Income stood at $155000.0 in 2022, then surged by 718.06% to $1.3 million in 2023, then tumbled by 97.87% to $27000.0 in 2024, then jumped by 14085.19% to $3.8 million in 2025, then tumbled by 102.95% to -$113000.0 in 2026.
• The last three Other Non Operating Income figures came in at -$113000.0 (Q1 2026), $3.8 million (Q4 2025), and -$5000.0 (Q3 2025), per Business Quant data.